Literature DB >> 27851656

Does Otosclerosis Affect Dark and Transitional Cells in the Human Vestibular Labyrinth?

Serdar Kaya1, Michael M Paparella, Sebahattin Cureoglu.   

Abstract

HYPOTHESIS: The density of vestibular dark cells (DCs) and vestibular transitional cells (TCs) can be quantitatively decreased in human temporal bones with otosclerosis.
BACKGROUND: Previous reports have shown that otosclerosis can lead to vestibular symptoms.
METHODS: We examined 61 human temporal bone specimens from 52 deceased donors with otosclerosis group-with and without endosteal involvement (EI), and with and without endolymphatic hydrops (EH)-versus 25 specimens from 18 age-matched controls. Using light microscopy, we evaluated the nonsensory epithelium of the lateral semicircular canal (LSC) and posterior semicircular canal (PSC) of the human vestibular labyrinth, focusing on the density of DCs and TCs.
RESULTS: In both the LSC and the PSC, as compared with the control group, the mean density of DCs significantly decreased in the EI (+) group, in the EI (+) and EH (+) subgroup, and in the EI (+) and EH (-) subgroup (p < 0.05). In addition, we found a significant difference in the mean density of DCs between the EI (+) group and the EI (-) group in the LSC and in the PSC (p < 0.05). But we found no significant difference in the mean density of TCs in any of the otosclerosis groups or subgroups as compared with the control group (p > 0.05).
CONCLUSION: We found a decrease in the density of DCs associated with EI in human temporal bone specimens with otosclerosis, regardless of the presence of EH. This decrease might cause damage in ion and water transportation, leading to vestibular symptoms.

Entities:  

Mesh:

Year:  2017        PMID: 27851656      PMCID: PMC5222754          DOI: 10.1097/MAO.0000000000001272

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  28 in total

1.  Clinical implications of inflammatory cytokines in the cochlea: a technical note.

Authors:  Joe C Adams
Journal:  Otol Neurotol       Date:  2002-05       Impact factor: 2.311

Review 2.  Stria vascularis and vestibular dark cells: characterisation of main structures responsible for inner-ear homeostasis, and their pathophysiological relations.

Authors:  R R Ciuman
Journal:  J Laryngol Otol       Date:  2008-06-23       Impact factor: 1.469

Review 3.  Otosclerosis: etiopathogenesis and histopathology.

Authors:  Sebahattin Cureoglu; Patricia A Schachern; Alfio Ferlito; Alessandra Rinaldo; Vladimir Tsuprun; Michael M Paparella
Journal:  Am J Otolaryngol       Date:  2006 Sep-Oct       Impact factor: 1.808

4.  Otosclerosis and vestibular degeneration.

Authors:  R Gussen
Journal:  Arch Otolaryngol       Date:  1973-06

5.  Otopathology in a case of type I Waardenburg's syndrome.

Authors:  S N Merchant; M J McKenna; C T Baldwin; A Milunsky; J B Nadol
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-09       Impact factor: 1.547

6.  Alpha 1-antitrypsin activity of perilymph. Occurrence during progression of otospongiosis.

Authors:  L G Chevance; J R Causse; J Bergès
Journal:  Arch Otolaryngol       Date:  1976-06

7.  Existence of voltage-dependent Ca2+ channels in vestibular dark cells: cytochemical and whole-cell patch-clamp studies.

Authors:  K Imon; T Amano; K Ishihara; M Sasa; K Yajin
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

8.  Effect of gentamycin on vestibular dark cells and melanocytes: an ultrastructural and cytochemical study.

Authors:  T Yoshihara; H Kaname; T Ishii; M Igarashi
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1994       Impact factor: 1.538

9.  Cochlear and otoconial abnormalities in capsular otosclerosis with hydrops.

Authors:  L G Johnsson; J E Hawkins; R C Rouse; F H Linthicum
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1982 Sep-Oct

10.  Quantitative assessment of vestibular otopathology in otosclerosis: A temporal bone study.

Authors:  Ömer Hızlı; Serdar Kaya; Patricia A Schachern; Geeyoun Kwon; Michael M Paparella; Sebahattin Cureoglu
Journal:  Laryngoscope       Date:  2015-08-26       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.